In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation

European Journal of Pharmacology

Volumn 450, Issue 1, 2002, Pages 11-17

  Baron, Roland ^a   Tsouderos, Yannis ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Bone resorption; Differentiation; Osteoclast; S12911 2

Indexed keywords

5 [BIS(CARBOXYMETHYL)AMINO] 2 CARBOXY 4 CYANO 3 THIOPHENEACETIC ACID DISTRONTIUM; CALCITRIOL; CARBONATE DEHYDRATASE II; S 12911 0; S 12911 5; STRONTIUM RANELATE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; CALCIUM CHANNEL STIMULATING AGENT; ORGANOMETALLIC COMPOUND; THIOPHENE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; IN VITRO STUDY; INCUBATION TIME; MACROPHAGE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE SLICE; ANALYSIS OF VARIANCE; ANIMAL; BIOSYNTHESIS; CHICKEN; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM;

ANALYSIS OF VARIANCE; ANIMAL; BONE MARROW CELLS; BONE RESORPTION; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CARBONIC ANHYDRASE II; CELL DIFFERENTIATION; CELLS, CULTURED; CHICKENS; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; IN VITRO; INTEGRIN ALPHAVBETA3; MACROPHAGES; ORGANOMETALLIC COMPOUNDS; OSTEOCLASTS; RATS; THIOPHENES; ANIMALS;

EID: 0037118899     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02040-X     Document Type: Article

References (39)

1. Motility and resorption: Osteoclastic activity in vitro
2. Long-term exposure to S12911-2 dose-dependently increases bone strength in intact female rats
3. The effect of pH on bone resorption by rat osteoclasts in vitro
4. Molecular mechanisms of bone resorption by the osteoclast
5. Reversal phase and osteoporosis: Defective coupling of resorption to formation in the pathogenesis of osteoporosis
6. Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100 KD lysosomal membrane protein at the osteoclast ruffled border
7. 3 regulates the expression of carbonic anhydrase II in nonerythroid avian bone marrow cells
8. Measurement of osteoclastic resorption pits with a tandem scanning microscope
9. New treatment strategies: Ipriflavone, strontium, vitamin D metabolites and analogs
10. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro
11. Calcitonin alters behavior of osteoclasts
12. Integrins and signal transduction pathways: The road taken
13. Incorporation and distribution of strontium in bone
14. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor
15. Histochemical identification of osteoclasts in undecalcified sections of human bone
16. Signal transduction from the extracellular matrix
17. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells
18. Cytoskeletal changes in osteoclasts during the resorption cycle
19. Organization of osteoclast microfilaments during the attachment to bone surface in vitro
20. 3 regulates the transcription of carbonic anhydrase II mRNA in avian myelomonocytes
21. Effects of strontium on bone formation and bone cells
22. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
23. S12911, a new agent containing strontium, inhibits bone loss due to immobilization in rats
24. Mechanisms of action and therapeutic potential of strontium in bone
25. The strontium salt S12911: A new candidate for the treatment of osteoporosis
26. Bone acid phosphatase, tartrate-resistant acid phosphatase as a marker of osteoclast function
27. Osteoporosis therapies
28. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone
29. Cells of bone: Proliferation, differentiation and hormonal regulation
30. Identification of a functional mononuclear precursor of the osteoclast in chicken medullary-bone marrow cultures
31. Therapy for osteoporosis: Miscellaneous and experimental agents
32. Past and future of anabolic agents
33. Integrin cytoplasmic domains: Mediator of cytoskeletal linkages and extra and intra cellular initiated transmembrane signaling
34. An ultrastructural study of osteoclasts and chondroclasts in poorly calcified mandible induced by high doses of strontium diet to fetal mice
35. Modulation of osteoclast differentiation
36. Effects of high calcium concentration on the functions and interactions of osteoblastic cells and monocytes and on the formation of osteoclast-like cells
37. The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure
38. The effects of extracellular pH on bone resorption by avian osteoclasts in vitro